Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial.
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA4003-LBA4003
Keyword(s):
LBA4003 The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Saturday, June 2, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4004-LBA4004
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. CRA3503-CRA3503
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA5002-LBA5002
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA8500-LBA8500
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4003-LBA4003
◽
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA10502-LBA10502
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA10008-LBA10008
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA4510-LBA4510
◽
Keyword(s):
2012 ◽
Vol 30
(15_suppl)
◽
pp. 4-4
◽
Keyword(s):